Evidence map›Paper›PMID 28524116›Full record

ArticleInternational journal of molecular sciences2017

Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.

Kwang-Youn Kim, Kwang-Il Park, Sang-Hun Kim, Sun-Nyoung Yu, Sul-Gi Park, Young Woo Kim, Young-Kyo Seo, Jin-Yeul Ma, Soon-Cheol Ahn

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 185 citations in OpenAlex.

  1. Article
  2. Review
  3. RecombinantAnimals : an open access journal from MDPI · 2025
    Article
  4. Article
  5. Article
  6. Silencing APLNR enhances the radiosensitivity of prostate cancer by modulating the PI3K/AKT/mTOR signaling pathway.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  7. Article
  8. Hypertonic Saline Induces Host Protective Immune Responses againstJournal of microbiology and biotechnology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2023
    Article
  15. Article
  16. Extracellular Vesicles Released from Macrophages Infected withInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Kwang-Youn KimDepartment of Herbal Formula, Medical Research Center (MRC-GHF), College of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Korea. lokyve@dhu.ac.kr.
Kwang-Il ParkKorean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Korea. kipark@kiom.re.kr.
Sang-Hun KimDepartment of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea. kshphone@nate.com.
Sun-Nyoung YuDepartment of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea. gurisn@naver.com.
Sul-Gi ParkDepartment of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea. betoje0728@gmail.com.
Young Woo KimDepartment of Herbal Formula, Medical Research Center (MRC-GHF), College of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Korea. ywkim@dhu.ac.kr.
Young-Kyo SeoSchool of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Korea. ykseo@unist.ac.kr.
Jin-Yeul MaKorean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Korea. jyma@kiom.re.kr.
Soon-Cheol AhnDepartment of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea. ahnsc@pusan.ac.kr.
Pusan National University · KRKorea Institute of Oriental Medicine · KRDaegu Haany University · KRUlsan National Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the interplay between autophagy and apoptosis has become an important factor in chemotherapy for cancer treatment. Inhibition of autophagy may be an effective strategy to improve the treatment of chemo-resistant cancer by consistent exposure to chemotherapeutic drugs. However, no reports have clearly elucidated the underlying mechanisms. Therefore, in this study, we assessed whether salinomycin, a promising anticancer drug, induces apoptosis and elucidated potential antitumor mechanisms in chemo-resistant prostate cancer cells. Cell viability assay, Western blot, annexin V/propidium iodide assay, acridine orange (AO) staining, caspase-3 activity assay, reactive oxygen species (ROS) production, and mitochondrial membrane potential were assayed. Our data showed that salinomycin alters the sensitivity of prostate cancer cells to autophagy. Pretreatment with 3-methyladenine (3-MA), an autophagy inhibitor, enhanced the salinomycin-induced apoptosis. Notably, salinomycin decreased phosphorylated of AKT and phosphorylated mammalian target of rapamycin (mTOR) in prostate cancer cells. Pretreatment with LY294002, an autophagy and PI3K inhibitor, enhanced the salinomycin-induced apoptosis by decreasing the AKT and mTOR activities and suppressing autophagy. However, pretreatment with PD98059 and SB203580, an extracellular signal-regulated kinases (ERK), and p38 inhibitors, suppressed the salinomycin-induced autophagy by reversing the upregulation of ERK and p38. In addition, pretreatment with

Indexed as

ApoptosisAutophagyCell ProliferationExtracellular Signal-Regulated MAP KinasesFlavonoidsHumansImidazolesMaleMAP Kinase Signaling SystemMembrane Potential, Mitochondrialp38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPolyether PolyketidesProto-Oncogene Proteins c-aktPyrans2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneExtracellular Signal-Regulated MAP KinasesFlavonoidsImidazolesMTOR protein, humanp38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPolyether PolyketidesProto-Oncogene Proteins c-aktPyransPyridinesReactive Oxygen SpeciessalinomycinSB 203580TOR Serine-Threonine Kinasesapoptosisautophagyprostate cancer cellsreactive oxygen speciessalinomycin

Identifiers

PMID28524116
PMCPMC5454997
OpenAlexW2615322840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.